2025 annual financial data

Sutro Biopharma 2025 Net margin

Direct answer

Net margin was -186.45%.

Operating income was -104.95M USD and net income was -191.09M USD.
Operating cash flow was -177.23M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
102.48M USD
Operating income
-104.95M USD
Net income
-191.09M USD
Operating cash flow
-177.23M USD